Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Montreal telemedicine company Dialogue Health Technologies Inc. has priced its impending initial public offering at $12 a share, the top end of its target range, after receiving strong demand from investors during the deal’s marketing period.

The company, which set out earlier this month to raise $100-million in an offering on the Toronto Stock Exchange at between $9 and $12 a share, received more than $1-billion worth of orders for the stock from investors, making it 10-times oversubscribed, two sources familiar with the transaction said. The company closed the book on orders from investors mid-Monday but did not increase the total size of the offering – 8.34 million shares at the offering price – meaning the company and its advisers anticipate leaving some room for the stock to jump after it starts trading next week under the ticker CARE.

The Globe and Mail is not disclosing the identities of the sources because they are not authorized to speak publicly about the matter.

Story continues below advertisement

The company’s underwriters also have a right to buy $15-million worth of stock from existing investors, including three entities associated with Power Corp. of Canada, at the issue price from some of the company’s shareholders.

Based on the number of common shares outstanding, the proposed offering would value Dialogue at $778-million based on its revised prospectus filed late Tuesday. The company’s two largest shareholders, Sun Life Assurance Co. of Canada and White Star Capital’s Fund VI, will own a combined 27.4 per cent of the company’s stock. The five year-old company has raised more than $100-million in venture capital to date.

Dialogue, led by chief executive officer Cherif Habib, chief product officer Anna Chif and chief technology officer Alexis Smirnov, is testing investor appetites for new Canadian technology issues at a time when stocks of digital companies have been subject to volatility. The tech-heavy Nasdaq fell 1.12 per cent Tuesday,

The offering is being led by National Bank of Canada, Royal Bank of Canada, Bank of Nova Scotia and Toronto-Dominion Bank. The rest of the underwriting syndicate includes CIBC World Markets, Desjardins Securities, Canaccord Genuity, iA Private Wealth, INFOR Financial and Laurentian Bank Securities.

Dialogue’s preliminary prospectus reveals it has experienced explosive growth, owing largely to the pandemic. Revenue from the company’s online health service in 2020 nearly tripled to $29-million from $10.1-million in 2019. That was up from $4-million in 2018. The service is now available to 2.5 million Canadians and their dependents, offered through four of Canada’s five largest group insurers. Dialogue lost $20.5-million in 2020, compared with a $12-million loss in 2019.

Total revenue reached $35.8-million in 2020 after Dialogue last year purchased Argumed Consulting Group GmbH, a German provider of occupational health and safety services, and Optima Global Health Inc., a Canadian employee-assistance-program seller. Annual recurring revenue was at a rate of $60-million early this year.

Valuations for public tech companies have skyrocketed since the start of the pandemic as people sheltering at home increasingly turned to online tools for shopping, workplace communications, training – and medical consultations.

Story continues below advertisement

The Globe first reported last summer that Dialogue was considering going public. Since then, several Canadian tech companies have hired bankers or filed to go public. Many initially met with a warm investor response in what has shaped up to be the busiest period for IPOs since the dot-com boom, though tech shares have eased off in recent weeks. MindBeacon Holdings Inc., a smaller and earlier-stage company than Dialogue offering online mental-health services, raised $65-million in a highly oversubscribed IPO in December. Industry observers believe Toronto telemedicine startup Maple Corp. could also be a near-term IPO candidate.

Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies